330 related articles for article (PubMed ID: 21143119)
1. Voltage-gated sodium channels: mutations, channelopathies and targets.
Andavan GS; Lemmens-Gruber R
Curr Med Chem; 2011; 18(3):377-97. PubMed ID: 21143119
[TBL] [Abstract][Full Text] [Related]
2. [Neuropathic pain syndromes and channelopathies].
Dohrn MF; Lampert A; Üçeyler N; Kurth I
Internist (Berl); 2019 Jan; 60(1):90-97. PubMed ID: 30564884
[TBL] [Abstract][Full Text] [Related]
3. Voltage-gated Sodium Channels and Blockers: An Overview and Where Will They Go?
Li ZM; Chen LX; Li H
Curr Med Sci; 2019 Dec; 39(6):863-873. PubMed ID: 31845216
[TBL] [Abstract][Full Text] [Related]
4. Cardiac sodium channelopathies.
Amin AS; Asghari-Roodsari A; Tan HL
Pflugers Arch; 2010 Jul; 460(2):223-37. PubMed ID: 20091048
[TBL] [Abstract][Full Text] [Related]
5. Voltage-gated sodium channels: action players with many faces.
Koopmann TT; Bezzina CR; Wilde AA
Ann Med; 2006; 38(7):472-82. PubMed ID: 17101538
[TBL] [Abstract][Full Text] [Related]
6. Conotoxin modulation of voltage-gated sodium channels.
Ekberg J; Craik DJ; Adams DJ
Int J Biochem Cell Biol; 2008; 40(11):2363-8. PubMed ID: 17951097
[TBL] [Abstract][Full Text] [Related]
7. Four novel tarantula toxins as selective modulators of voltage-gated sodium channel subtypes.
Bosmans F; Rash L; Zhu S; Diochot S; Lazdunski M; Escoubas P; Tytgat J
Mol Pharmacol; 2006 Feb; 69(2):419-29. PubMed ID: 16267209
[TBL] [Abstract][Full Text] [Related]
8. A sodium channel pore mutation causing Brugada syndrome.
Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
[TBL] [Abstract][Full Text] [Related]
9. Actions of sea anemone type 1 neurotoxins on voltage-gated sodium channel isoforms.
Wanke E; Zaharenko AJ; Redaelli E; Schiavon E
Toxicon; 2009 Dec; 54(8):1102-11. PubMed ID: 19393679
[TBL] [Abstract][Full Text] [Related]
10. [Progress in sodium channelopathies and biological functions of voltage-gated sodium channel blockers].
Wang H; Gou M; Xiao R; Li Q
Sheng Wu Gong Cheng Xue Bao; 2014 Jun; 30(6):875-90. PubMed ID: 25212005
[TBL] [Abstract][Full Text] [Related]
11. Interaction between voltage-gated sodium channels and the neurotoxin, tetrodotoxin.
Lee CH; Ruben PC
Channels (Austin); 2008; 2(6):407-12. PubMed ID: 19098433
[TBL] [Abstract][Full Text] [Related]
12. Sodium channelopathies of skeletal muscle result from gain or loss of function.
Jurkat-Rott K; Holzherr B; Fauler M; Lehmann-Horn F
Pflugers Arch; 2010 Jul; 460(2):239-48. PubMed ID: 20237798
[TBL] [Abstract][Full Text] [Related]
13. Inherited sodium channelopathies: a continuum of channel dysfunction.
Viswanathan PC; Balser JR
Trends Cardiovasc Med; 2004 Jan; 14(1):28-35. PubMed ID: 14720472
[TBL] [Abstract][Full Text] [Related]
14. Painful Na-channelopathies: an expanding universe.
Waxman SG
Trends Mol Med; 2013 Jul; 19(7):406-9. PubMed ID: 23664154
[TBL] [Abstract][Full Text] [Related]
15. An unexpected role for brain-type sodium channels in coupling of cell surface depolarization to contraction in the heart.
Maier SK; Westenbroek RE; Schenkman KA; Feigl EO; Scheuer T; Catterall WA
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):4073-8. PubMed ID: 11891345
[TBL] [Abstract][Full Text] [Related]
16. SCN5A channelopathies--an update on mutations and mechanisms.
Zimmer T; Surber R
Prog Biophys Mol Biol; 2008; 98(2-3):120-36. PubMed ID: 19027780
[TBL] [Abstract][Full Text] [Related]
17. Tetrodotoxin (TTX) as a therapeutic agent for pain.
Nieto FR; Cobos EJ; Tejada MÁ; Sánchez-Fernández C; González-Cano R; Cendán CM
Mar Drugs; 2012 Feb; 10(2):281-305. PubMed ID: 22412801
[TBL] [Abstract][Full Text] [Related]
18. Sodium channelopathies in neurodevelopmental disorders.
Meisler MH; Hill SF; Yu W
Nat Rev Neurosci; 2021 Mar; 22(3):152-166. PubMed ID: 33531663
[TBL] [Abstract][Full Text] [Related]
19. Insect-selective spider toxins targeting voltage-gated sodium channels.
Nicholson GM
Toxicon; 2007 Mar; 49(4):490-512. PubMed ID: 17223149
[TBL] [Abstract][Full Text] [Related]
20. Mutations in cardiac sodium channels: clinical implications.
Liu H; Clancy C; Cormier J; Kass R
Am J Pharmacogenomics; 2003; 3(3):173-9. PubMed ID: 12814325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
